Single Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Doses of Zolpidem in Children
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
This is a multicenter trial to evaluate the single-dose safety, tolerability and
pharmacokinetics-pharmacodynamics of Zolpidem in a group of children with sleep disturbances
stratified by age and dose.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)